Literature DB >> 30526180

Reduction of hospitalization and transfusion support in patients with acute promyelocytic leukemia treated with arsenic trioxide plus all-trans retinoic acid compared to chemotherapy plus all-trans retinoic acid.

Francesco Autore1, Patrizia Chiusolo1,2, Federica Sorà1,2, Sabrina Giammarco1, Luca Laurenti1,2, Idanna Innocenti1, Elisabetta Metafuni1, Nicola Piccirillo1,2, Livio Pagano1,2, Andrea Bacigalupo1,2, Giuseppe Leone1,2, Simona Sica1,2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30526180     DOI: 10.1080/10428194.2018.1522436

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


× No keyword cloud information.
  1 in total

1.  Efficacy and Tolerability of First Line Arsenic Trioxide in Combination With All-Trans Retinoic Acid in Patients With Acute Promyelocytic Leukemia: Real Life Experience.

Authors:  Francesco Autore; Patrizia Chiusolo; Federica Sorà; Sabrina Giammarco; Luca Laurenti; Idanna Innocenti; Elisabetta Metafuni; Nicola Piccirillo; Livio Pagano; Simona Sica
Journal:  Front Oncol       Date:  2021-07-16       Impact factor: 6.244

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.